NCT06922006

Brief Summary

The goal of this observational study is to investigate the feasibility of ultrasound-guided percutaneus nephrolithotomy in patients with kidney stones. The main question's it aims to answer are: Does the use of ultrasound in percutaneus nephrolithotomy affect stone free rates, defined by no stone or stone \<2mm, on follow up visit? Does the use of ultrasound in percutaneus nephrolithotomy affect complication rates, categorized by Clavien system? Researchers will compare ultrasound-guided percutaneus nephrolithotomy to traditional nephrolithotomy using fluoroscopy to see if outcomes differ. Participants will be chosen for any of the above interventions at surgeon's discretion.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
67

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 26, 2024

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

March 27, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 10, 2025

Completed
21 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

April 10, 2025

Status Verified

April 1, 2025

Enrollment Period

1.1 years

First QC Date

March 27, 2025

Last Update Submit

April 8, 2025

Conditions

Keywords

PCNL

Outcome Measures

Primary Outcomes (1)

  • Stone free rates

    The rate of patients with no stone, or \<2mm stone on follow up visit.

    4-6 weeks after surgery.

Secondary Outcomes (12)

  • Complication rates

    From date of surgery to 30 days post surgery.

  • ED visits

    From surgery to 30 days after surgery.

  • Re-admission rates

    From surgery to 30 days after surgery.

  • Required additional procedure after PCNL.

    From surgery to 30 days after surgery.

  • End of case residual stone prescense.

    At the end of surgery (In the operating room).

  • +7 more secondary outcomes

Study Arms (3)

Radiation-free PCNL

Cases that were done using ultrasound as the only imaging modality during the entire procedure.

Procedure: Percutaneus nephrolithotomy (PCNL)

Fluoroscopy-guided PCNL

Traditional PCNL's that were planned and performed with fluoroscopy.

Procedure: Percutaneus nephrolithotomy (PCNL)

Converted from radiation-free to fluoroscopy-guided PCNL

Cases that were planned to be done with ultrasound but that ended up having to use fluoroscopy.

Procedure: Percutaneus nephrolithotomy (PCNL)

Interventions

Percutaneus nephrolithotomy (PCNL) for removal of large kidney stones

Converted from radiation-free to fluoroscopy-guided PCNLFluoroscopy-guided PCNLRadiation-free PCNL

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

General population with kidney stones larger than 20mm.

You may qualify if:

  • Scheduled percutaneus nephrolithotomy by Dr. Roger Sur between 2022 and 2025 at UCSD Hillcrest.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California San Diego, Hillcrest

San Diego, California, 92103, United States

Location

MeSH Terms

Conditions

Kidney Calculi

Condition Hierarchy (Ancestors)

NephrolithiasisKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrolithiasisUrinary CalculiMale Urogenital DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Roger L Sur, MD

    University of California, San Diego

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Urology

Study Record Dates

First Submitted

March 27, 2025

First Posted

April 10, 2025

Study Start

March 26, 2024

Primary Completion

May 1, 2025

Study Completion

June 1, 2025

Last Updated

April 10, 2025

Record last verified: 2025-04

Locations